Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,942,343 papers from all fields of science
Search
Sign In
Create Free Account
Growth delay
Known as:
delayed disorder growth
, Delayed growth
, delays growth
Expand
A deficiency or slowing down of growth pre- and postnatally. [HPO:probinson]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Failure to Thrive
Fetal malnutrition without mention of light-for-dates
Growth retardation
HYPOTHYROIDISM, CONGENITAL, DUE TO THYROID DYSGENESIS
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
The Schedule-Dependent Effects of the Novel Antifolate Pralatrexate and Gemcitabine Are Superior to Methotrexate and Cytarabine in Models of Human Non-Hodgkin's Lymphoma
L. Toner
,
R. Vrhovac
,
+6 authors
O. O’Connor
Clinical Cancer Research
2006
Corpus ID: 9583262
Purpose: Methotrexate is known to synergize with cytarabine [1-β-d-arabinofuranosylcytosine (ara-C)] in a schedule-dependent…
Expand
Highly Cited
2004
Highly Cited
2004
Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors
L. Rodrigues
,
F. Howe
,
J. Griffiths
,
Simon P Robinson
Journal of Magnetic Resonance Imaging
2004
Corpus ID: 36750024
To test the prognostic potential of tumor R2* with respect to radiotherapeutic outcome. Blood oxygenation level dependent (BOLD…
Expand
Highly Cited
2001
Highly Cited
2001
C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.
S. Nasu
,
K. Ang
,
Z. Fan
,
L. Milas
International Journal of Radiation Oncology…
2001
Corpus ID: 28940075
Highly Cited
1999
Highly Cited
1999
Maximizing therapeutic gain with gemcitabine and fractionated radiation.
K. Mason
,
L. Milas
,
+5 authors
K. Ang
International Journal of Radiation Oncology…
1999
Corpus ID: 26011428
Highly Cited
1994
Highly Cited
1994
Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acid.
Stephen Cliffe
,
Maryann L. Taylor
,
Michael D. Rutland
,
B. Baguley
,
Richard P. Hill
,
William R. Wilson
International Journal of Radiation Oncology…
1994
Corpus ID: 28809575
Highly Cited
1993
Highly Cited
1993
Ring chromosome 15 involving deletion of the insulin-like growth factor 1 receptor gene in a patient with features of Silver-Russell syndrome.
T. Tamura
,
T. Tohma
,
+4 authors
N. Niikawa
Clinical Dysmorphology
1993
Corpus ID: 21075921
An 11-year-old girl with de novo r(15) (p12q26.3) with a clinical diagnosis of Silver-Russell syndrome (SRS) is presented. She…
Expand
Highly Cited
1991
Highly Cited
1991
Tumour cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumours.
A. Begg
,
I. Hofland
,
J. Kummermehr
European Journal of Cancer
1991
Corpus ID: 30140126
Highly Cited
1990
Highly Cited
1990
Comparison between in vitro radiosensitivity and in vivo radioresponse in murine tumor cell lines. II: In vivo radioresponse following fractionated treatment and in vitro/in vivo correlations.
R. Bristow
,
R. Hill
International Journal of Radiation Oncology…
1990
Corpus ID: 37837085
Highly Cited
1985
Highly Cited
1985
The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin.
P. Lelieveld
,
M. Scoles
,
J. Brown
,
R. Kallman
International Journal of Radiation Oncology…
1985
Corpus ID: 24005542
Highly Cited
1971
Highly Cited
1971
The 4p- syndrome. A clinically recognizable chromosomal deletion syndrome.
R. Guthrie
,
J. Aase
,
A. Asper
,
D. W. Smith
A M A Journal of Diseases of Children
1971
Corpus ID: 44404204
Partial deletion of the short arm of chromosome 4 results in a clinically recognizable and distinct syndrome. Common features…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE